triethylenemelamine has been researched along with Uremia in 3 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MARTIN, H | 1 |
| PICCINI, A | 1 |
| TARGETTI, M | 1 |
| KRAVITZ, SC | 1 |
| DIAMOND, HD | 1 |
| CRAVER, LF | 1 |
3 other studies available for triethylenemelamine and Uremia
| Article | Year |
|---|---|
[Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].
Topics: Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Triethylenemelamine; Uremia | 1953 |
[MALIGNANT HISTOPLASMOCYTOSIS (A STATISTICO-CLINICAL STUDY)].
Topics: Adrenal Cortex Hormones; Albuminuria; Alkaline Phosphatase; Androgens; Asthenia; Blood Protein Elect | 1963 |
Uremia complicating leukemia chemotherapy; report of a case treated with triethylene melamine.
Topics: Humans; Leukemia; Triethylenemelamine; Uremia; Urologic Diseases | 1951 |